BridgePoint Medical Inc.

2800 Campus Drive, #50
Plymouth
MN
55441
U.S.
Phone: 
(763) 225-8500
Fax: 
(763) 225-8718
http://www.bridgepointmedical.com
Product Categories: Catheters CTO Crossing catheters

Related Articles

Cath Lab

Boston Scientific to Acquire CTO Catheter Company BridgePoint Medical
When to Consider Revascularization of Coronary Chronic Total Occlusions
BridgePoint Licensing CTO Peripheral Vascular Products to Covidien
Chronic Total Occlusion Catheter System Cleared in Europe

CTO Crossing catheters

Boston Scientific to Acquire CTO Catheter Company BridgePoint Medical
When to Consider Revascularization of Coronary Chronic Total Occlusions
Crossboss CTO Catheter, Sapien, Watchman Among Picks for Best Cardiac Devices of 2011
BridgePoint Licensing CTO Peripheral Vascular Products to Covidien
First Patient Enrolled in Trial of Peripheral Chronic Total Occlusion Device
FDA Expands Indication for CrossBoss, Stingray to Treat CTOs
Final FDA Review Requested for Coronary CTO Crossing Catheters
Chronic Total Occlusion Catheter System Cleared in Europe
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss, Stingray Devices in CTO Procedure

Peripheral Arterial Disease (PAD) Treatment Devices

Boston Scientific to Acquire CTO Catheter Company BridgePoint Medical
First Patient Enrolled in Trial of Peripheral Chronic Total Occlusion Device

Left Atrial Appendage (LAA) Occluders

Crossboss CTO Catheter, Sapien, Watchman Among Picks for Best Cardiac Devices of 2011

Heart Valve Repair

Crossboss CTO Catheter, Sapien, Watchman Among Picks for Best Cardiac Devices of 2011

Catheter

BridgePoint Licensing CTO Peripheral Vascular Products to Covidien

Catheters

BridgePoint Licensing CTO Peripheral Vascular Products to Covidien
FDA Expands Indication for CrossBoss, Stingray to Treat CTOs
Final FDA Review Requested for Coronary CTO Crossing Catheters
Chronic Total Occlusion Catheter System Cleared in Europe
BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss, Stingray Devices in CTO Procedure

Clinical Trial/Study

First Patient Enrolled in Trial of Peripheral Chronic Total Occlusion Device
Final FDA Review Requested for Coronary CTO Crossing Catheters